Syndicate

Latest California Healthline Stories

A Decades-Long Drop in Teen Births Is Slowing, and Advocates Worry a Reversal Is Coming

After three decades of declines in teen pregnancies, data shows the rates are starting to plateau. The reversal of “Roe v. Wade,” coupled with efforts to suspend sex education in schools and higher rates of youth mental health issues post-pandemic, could culminate in a perfect storm.

Massive Kaiser Permanente Strike Looms as Talks Head to the Wire

Both sides, still at loggerheads over pay and staffing, agreed to keep bargaining after unions announced a possible strike Oct. 4-7. If no deal is reached, a walkout by about 75,000 KP workers in five states could disrupt care.

Officials Agree: Use Settlement Funds to Curb Youth Addiction. But the ‘How’ Gets Hairy.

Parents, educators, and elected officials agree that investing in school-based prevention efforts could help curb the rising rate of youth drug overdoses. The well-known D.A.R.E. program is one likely choice, but its effectiveness is in question.

KFF Health News' 'What the Health?': Countdown to Shutdown

Congress appears to be careening toward a government shutdown, as a small band of House conservatives vow to block any funding for the fiscal year that begins Oct. 1 unless they win deeper cuts to health and other domestic programs. Meanwhile, former President Donald Trump continues to roil the GOP presidential primary field, this time with comments about abortion. Alice Miranda Ollstein of Politico, Rachel Cohrs of Stat, and Tami Luhby of CNN join KFF Health News chief Washington correspondent Julie Rovner to discuss these issues and more. Also, for “extra credit,” the panelists suggest health policy stories they read this week they think you should read, too.

As Younger Children Increasingly Die by Suicide, Better Tracking and Prevention Is Sought

Decades-long systemic shortcomings have left suicide among children ages 5 to 11 poorly tracked and addressed. Now, as rates appear to be rising, advocates are strengthening efforts to screen for problems and prevent deaths in younger children.

Save Billions or Stick With Humira? Drug Brokers Steer Americans to the Costly Choice

Thousands of patients with autoimmune diseases who rely on Humira, with a list price of $6,600 a month, could get financial relief from new low-cost rivals. So far, the pharmacy benefit managers that control drug prices in America have not delivered on those savings.